________________________________
From: Hannan, Terry J
Sent: Tuesday, 9 August 2011 9:54 PM
To: '[email protected]'; [email protected]
Subject: RE: [OPENMRS-IMPLEMENTERS] Opinion on Best way to manage Fixed
Dose Combo HIV drugs
Evelyn, from my "old" MUMPS dictionary days in OCIS, are not the concept
dugs [Stavudine/Lamivudine/Nevirapine] the "concept" but the doses
(?data) make them different?
For example if you take a drug "concept" Penicillin and have dose
differences e.g. 250mg/500mg/1Gm how do you handle these?
I feel I may be out of my league here but your words bring back memories
from the 1990s of building dictionaries.
If this is useless commentaries just use DEL.
Terry
________________________________
From: [email protected] [mailto:[email protected]] On
Behalf Of Evelyn Castle
Sent: Tuesday, 9 August 2011 9:25 PM
To: [email protected]
Subject: [OPENMRS-IMPLEMENTERS] Opinion on Best way to manage Fixed Dose
Combo HIV drugs
Hi all,
I am trying to determine the best way to have fixed dose combination
drugs in our OMRS system. Here is what I am doing now... is this what
most people are doing or is there a better way?
1. When entering them as a "concept drug", I have to enter all the drug
names together (ex: Stavudine/Lamivudine/Nevirapine). And, sense I want
to be able to distinguish between the different dose combinations, I
would need to add the dose into the "name" as well.
So I would have 2 different concept drugs: 1.
Stavudine/Lamivudine/Nevirapine (12/60/100mg)
2.
Stavudine/Lamivudine/Nevirapine (6/30/50mg)
Since the dose in "dose strength" can't have "/" in it, there is no way
to put the min and max dose strength in the concept drug and then have
the provider type in the dose strength in the form. So, I would just put
"1 pill" as the dose strength.
Technically, these are different "fixed dose combination drugs" so
creating them as different concept drugs works right? They would both
have the same overall "concept" which is
Stavudine/Lamivudine/Nevirapine.
If I move forward like this, for reporting, can I report on the number
of people who received the "concept drug"
[Stavudine/Lamivudine/Nevirapine (12/60/100mg)] vs. the concept
[Stavudine/Lamivudine/Nevirapine]?
Any opinions/advice are more than welcome!
Thanks
Evelyn
--
Evelyn Castle
Co-Director, eHealth Nigeria
+1 415 545 8289 (US)
website: http://www.eHealthNigeria.org
blog: http://www.evelyncastle.com
skype: evelynlcastle
________________________________
Click here to unsubscribe
<mailto:[email protected]?body=SIGNOFF%20openmrs-implement-l>
from OpenMRS Implementers' mailing list
Want to Get Healthy?
The Tasmania Government's Get Healthy Information and Coaching Service provides
free information and coaching support to Tasmanian adults who would like to
learn healthier eating habits, be more active or achieve and maintain a healthy
weight. Call 1300 806 258 between 8am and 8pm, Monday to Friday or visit
www.gethealthy.tas.gov.au for more information.
CONFIDENTIALITY NOTICE AND DISCLAIMER
The information in this transmission may be confidential and/or protected by
legal professional privilege, and is intended only for the person or persons to
whom it is addressed. If you are not such a person, you are warned that any
disclosure, copying or dissemination of the information is unauthorised. If you
have received the transmission in error, please immediately contact this office
by telephone, fax or email, to inform us of the error and to enable
arrangements to be made for the destruction of the transmission, or its return
at our cost. No liability is accepted for any unauthorised use of the
information contained in this transmission. If the transmission contains
advice, the advice is based on instructions in relation to, and is provided to
the addressee in connection with, the matter mentioned above. Responsibility is
not accepted for reliance upon it by any other person or for any other purpose.
_________________________________________
To unsubscribe from OpenMRS Implementers' mailing list, send an e-mail to
[email protected] with "SIGNOFF openmrs-implement-l" in the body
(not the subject) of your e-mail.
[mailto:[email protected]?body=SIGNOFF%20openmrs-implement-l]
